Compound Detail
CHEMBL1645462
AC-480 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12
Basic Information
| ChEMBL ID | CHEMBL1645462 |
| Name | AC-480 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | LUJZZYWHBDHDQX-QFIPXVFZSA-N |
11
Targets
18
Activities
2
Assay Types
30
PK Parameters
20
Publications
4
Known Names
3
Indications
3
Mechanisms
Molecular Properties
530.6
MW (Da)
3.86
ALogP
10
HBA
3
HBD
119.6
PSA (Ų)
0.29
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Epidermal growth factor receptor erbB1 inhibitor | INHIBITOR | Epidermal growth factor receptor | ✓ | ✓ |
| Receptor protein-tyrosine kinase erbB-2 inhibitor | INHIBITOR | Receptor tyrosine-protein kinase erbB-2 | ✓ | ✓ |
| Receptor protein-tyrosine kinase erbB-4 inhibitor | INHIBITOR | Receptor tyrosine-protein kinase erbB-4 | ✓ | ✓ |
Indications
Neoplasms Neoplasms Paraganglioma
Activity Summary
IC50 16 meas. best 7.7
Kd 2 meas. best 8.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Epidermal growth factor receptor CHEMBL203 | Kd | 8.52 | 8.52 | 3.0 | 1 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 7.7 | 7.5667 | 20.0 | 3 |
| Receptor tyrosine-protein kinase erbB-2 CHEMBL1824 | IC50 | 7.66 | 7.6067 | 22.0 | 3 |
| Receptor tyrosine-protein kinase erbB-4 CHEMBL3009 | IC50 | 6.72 | 6.72 | 190.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 6.62 | 6.62 | 240.0 | 1 |
| BT-474 CHEMBL614529 | IC50 | 6.51 | 6.51 | 310.0 | 1 |
| NCI-N87 CHEMBL614197 | IC50 | 6.35 | 6.35 | 450.0 | 2 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 5.8 | 5.36 | 1600.0 | 2 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 5 CHEMBL4948 | Kd | 5.23 | 5.23 | 5927.0 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 4.92 | 4.92 | 12000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 77992.32 | ng.hr.mL-1 | Mus musculus |
| AUC | 1538.62 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 7427.84 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 1910.02 | ng.hr.mL-1 | Macaca fascicularis |
| AUC | 7056.45 | ng.hr.mL-1 | Mus musculus |
| CL | 21.3 | mL.min-1.kg-1 | Mus musculus |
| CL | 41.6 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 24.8 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 10.5 | mL.min-1.kg-1 | Macaca fascicularis |
| Cmax | 18000.0 | nM | Mus musculus |
| Cmax | 600.0 | nM | Rattus norvegicus |
| Cmax | 1200.0 | nM | Canis lupus familiaris |
| Cmax | 500.0 | nM | Macaca fascicularis |
| Cmax | 4100.0 | nM | Mus musculus |
| Cmax | 4100.0 | nM | Mus musculus |
| F | 83.0 | % | Mus musculus |
| F | 40.0 | % | Rattus norvegicus |
| F | 49.0 | % | Canis lupus familiaris |
| F | 31.0 | % | Macaca fascicularis |
| MRT | 3.7 | hr | Mus musculus |
| MRT | 2.8 | hr | Rattus norvegicus |
| MRT | 6.9 | hr | Canis lupus familiaris |
| MRT | 6.4 | hr | Macaca fascicularis |
| T1/2 | 2.7 | hr | Mus musculus |
| T1/2 | 2.8 | hr | Rattus norvegicus |
| T1/2 | 7.2 | hr | Canis lupus familiaris |
| T1/2 | 5.7 | hr | Macaca fascicularis |
| Tmax | 1.0 | hr | Mus musculus |
| Tmax | 0.7 | hr | Rattus norvegicus |
| Tmax | 2.3 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19821562 | 10.1021/jm9010065 | Unchecked | 42 |
| 19821562 | 10.1021/jm9010065 | Mus musculus | 13 |
| 19821562 | 10.1021/jm9010065 | Rattus norvegicus | 8 |
| 19821562 | 10.1021/jm9010065 | Canis familiaris | 8 |
| 19821562 | 10.1021/jm9010065 | Cynomolgus monkey | 8 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 6 |
| 19821562 | 10.1021/jm9010065 | NON-PROTEIN TARGET | 6 |
| 19821562 | 10.1021/jm9010065 | Plasma | 5 |
| 19821562 | 10.1021/jm9010065 | Epidermal growth factor receptor and ErbB2 (HER1 and HER2) | 4 |
| 19821562 | 10.1021/jm9010065 | NCI-N87 | 4 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 4 |
| 19821562 | 10.1021/jm9010065 | L2987 | 3 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 3 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 19821562 | 10.1021/jm9010065 | ADMET | 2 |
| 21177105 | 10.1016/j.bmcl.2010.11.100 | Mus musculus | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 21177105 | 10.1016/j.bmcl.2010.11.100 | NCI-N87 | 2 |
| 19821562 | 10.1021/jm9010065 | Cytochrome P450 3A4 | 2 |
| 38157838 | 10.1016/j.bmc.2023.117561 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine